Biotechnology News

September 16, 2014

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Announces Issue of a New Patent for Beleodaq(TM) (belinostat) for Injection with Patent Term Adjustment till 2027

September 16, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma (NASDAQ: XLRN) announces series of online educational seminars with thought-leading experts in diseases for which sotatercept and luspatercept (ACE-536) are being developed.

September 16, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that the U.S. Patent and...

September 16, 2014

EMERYVILLE, CA--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, announced today that the company will be...

September 16, 2014

NEW YORK--(BUSINESS WIRE)--SIGA Technologies, Inc. (NASDAQ:SIGA), a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced today that it has filed a voluntary petition...

September 16, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Appoints Dr. Mai H. Le to Position of Chief Medical Officer and Names Dr. Robert H. Pierce as Chief Scientific Officer

September 16, 2014

INGELHEIM, Germany & INDIANAPOLIS--(BUSINESS WIRE)--Boehringer Ingelheim and Eli Lilly and Company today presented results from a 52-week Phase III study that demonstrated sustained efficacy of the investigational empagliflozin/linagliptin...

September 16, 2014

DARMSTADT, Germany--(BUSINESS WIRE)--Merck Serono today announced the establishment of a long-term strategic partnership with Lupin Limited. Lupin will support Merck Serono in the implementation of their General Medicines portfolio.

September 16, 2014

ABERDEEN, Scotland--(BUSINESS WIRE)--NovaBiotics Ltd, the Aberdeen-based clinical-stage biotechnology company (“NovaBiotics” or the “Company”), today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation for...

September 16, 2014

HELSINKI--(BUSINESS WIRE)--The Ginolis Delilah™ lateral flow assembly (LFA) product is built on the Ginolis’s productized modular Ginolis Delilah™ robotic platform, which has a proven track record for various Point of Care (POC) diagnostic...

September 16, 2014

AMSTERDAM--(BUSINESS WIRE)--In findings that may eventually change the way breast cancer is evaluated and treated, a new study reports that the BluePrint genomic test provides more accurate information about the molecular subtype of a specific...

September 16, 2014

OXFORD & NEWCASTLE, United Kingdom--(BUSINESS WIRE)--e-Therapeutics plc (AIM: ETX), the drug discovery and development company, today announces its half year results for the six months ended 31 July 2014.

September 16, 2014

SEOUL, South Korea--(BUSINESS WIRE)--Panagene has been in focus on news of having developed a commercial ctDNA test kits that can detect mutated oncogene through blood test alone. This technology is based on PNA (Peptide Nucleic Acid) and it can...

September 16, 2014

CAMBRIDGE, Mass. & BRISBANE, Queensland--(BUSINESS WIRE)--Vaxxas announced the initiation of a research project to evaluate Vaxxas' proprietary Nanopatch™ platform for delivery of polio vaccine, funded by the World Health Organization (WHO...

September 16, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--Data show that pulmonary artery pressure monitoring reduced HF hospitalization in patients with kidney failure by 42% compared to standard care alone and didn't adversely affect kidney function.

September 15, 2014

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the FDA has granted tentative approval for UCERIS® (budesonide) rectal foam for the induction of remission in patients with active mild-to-moderate...

September 15, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals announces the appointment of Bruce Peacock to its board of directors and audit committee.

September 15, 2014

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa announced it intends to offer shares of its common stock in an underwritten public offering.

September 15, 2014

COLUMBIA, Md.--(BUSINESS WIRE)--Grafix® Featured in Plenary Session Oral Presentation at the Joint Annual Meeting of the Eastern and New England Vascular Societies

September 15, 2014

MINNEAPOLIS--(BUSINESS WIRE)--LifeScience Alley announces Medtronic CEO Omar Ishrak to speak at conference on November 19. Other keynotes come from Mayo Clinic, SharedClarity and BlueCross BlueShield Assoc.

September 15, 2014

BOSTON--(BUSINESS WIRE)--EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ:EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, announced today that it has...

September 15, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, today announced that interim results from the first-in-human ALKA-372-001 Phase I clinical trial of RXDX-101, the company’s proprietary...

September 15, 2014

MEMPHIS, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that Kevin D. Cordell has been appointed President, U.S. Extremities, effective September 29, 2014. Mr. Cordell will have operating responsibility for...

September 15, 2014

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: RaySearch Laboratories AB (STO:RAYB) and Mevion Medical Systems, Inc., two companies that are leading the field of proton therapy, are announcing a partnership to develop advanced treatment planning...

September 15, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck announced data from the pivotal Phase 3 fracture outcomes study for odanacatib in postmenopausal women with osteoporosis. Odanacatib is Merck’s investigational once-weekly cathepsin K inhibitor

September 15, 2014

SAN FRANCISCO--(BUSINESS WIRE)--Novalis Circle community examines the emerging role of radiosurgery for aggressive, personalized cancer treatment.

September 15, 2014

PARK CITY, Utah--(BUSINESS WIRE)--Andre Bouhasin, MD, an Interventional Cardiologist with West County Heart and Vascular Diagnostics, St. Louis, Missouri, used a novel device to remove blood clots and emboli from a protective filter and native...

September 15, 2014

BROOKLYN, N.Y.--(BUSINESS WIRE)--Endocrine Technology, L.L.C. is a New York-based biotechnology company detailed at www.etbondusa.com. Kumar Shah, M.D., President of the company,...

September 15, 2014

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services,...

September 15, 2014

--(BUSINESS WIRE)--BIO and cellulosic biofuel companies Abengoa, POET-DSM, and GranBio will update the status of cellulosic biofuel production during this teleconference for reporters.

September 15, 2014

COLUMBUS, Ohio--(BUSINESS WIRE)--Last autumn, Ohio’s bioscience industry convened its Annual Conference in its most central metropolis, Columbus. This year, however, BioOhio changes the scope of its Annual Conference by taking it “on the road.”...

September 15, 2014

PLYMOUTH, Minn.--(BUSINESS WIRE)--Rotation Medical Initiates Post-Market Clinical Study of Rotator Cuff Repair System with Bioinductive Implant

September 15, 2014

MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) today announced the European launch of the 4Kscore ™ Test, the only blood test that accurately identifies risk for aggressive prostate cancer, through its wholly owned subsidiary, OPKO Health...

September 15, 2014

GEORGETOWN, Texas--(BUSINESS WIRE)--Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapies, announced today that it has expanded its series C financing with an...

September 15, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--The United States FDA has approved Baxter's RIXUBIS for routine prophylactic treatment, control and prevention of bleeding episodes, and perioperative management in children with hemophilia B.

September 15, 2014

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, a clinical-stage biotechnology company pioneering microRNA-based Replacement Therapy to treat cancer, today announced the appointment of Lawrence M. Alleva, a former partner with...

September 15, 2014

ALAMEDA, Calif. & LONDON--(BUSINESS WIRE)--OncoCyte Corporation, a subsidiary of BioTime, Inc. (NYSE MKT: BTX), and Abcodia Ltd., a UK-based company focusing on the early detection of cancer, today announced their collaboration focused on the...

September 15, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akashi acquired rights to GsMTx-4, a small molecule developed by Tonus Therapeutics to address calcium level imbalance in muscle, a critical issue in DMD contributing to loss of function.

September 15, 2014

--(BUSINESS WIRE)--Tech Council of Maryland Debuts Technology Community Speaker Series on October 7 with CEA’s Gary Shapiro

September 15, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops targeted anticancer therapies using its antibody-drug conjugate (ADC) technology, today announced the appointment of Sandra E. Poole as Senior...

September 15, 2014

IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--A new study reports that the BluePrint genomic test provides more accurate information about the molecular subtype of breast cancer than does conventional IHC-FISH pathology testing.

September 15, 2014

BILLERICA, Mass.--(BUSINESS WIRE)--EMD Millipore, the Life Science division of Merck KGaA, announced it has received two R&D Magazine 100 Awards for innovative products released to market in 2014.

September 15, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology has released its VIA Spinous Process Fixation System featuring independently compressible superior & inferior plates contoured to maximize the fit between the implant & associated laminae.

September 15, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced it has been awarded a $200,000 grant by the US FDA to cooperatively develop improved modeling and simulation capabilities for drugs designed to be applied to the eye.

September 15, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Kevin Sarney, CPA, has joined Enumeral as VP of Finance and Chief Accounting Officer. Recently transitioning to a public company, Enumeral discovers and develops novel antibody immunotherapies.

September 15, 2014

LONDON--(BUSINESS WIRE)--AHF joins IAPAC, UNAIDS sponsoring London Conference on Antiretrovirals, Sept. 18 & 19--conference to focus on prevention and treatment methods and Treatment as Prevention (TasP)

September 15, 2014

MULHOUSE, France & SAN CARLOS, Calif.--(BUSINESS WIRE)--CellProThera and BioCardia partner in Phase II EXCELLENT Trial studying blood stem cell therapy for acute myocardial infarction delivered via the Helix transendocardial delivery system...

September 15, 2014

LOS ANGELES--(BUSINESS WIRE)--NantBioScience, a NantWorks company focused on the discovery and development of innovative treatments for diseases with high unmet medical need, announced today a research collaboration and an exclusive worldwide...